| Bioactivity | Quinazosin dihydrochloride is an antihypertensive agent that exhibits activity related to the suppression of granulopoiesis, leading to neutropenia and leukopenia. Quinazosin dihydrochloride has been shown to induce significant reductions in neutrophil counts in animal studies. Quinazosin dihydrochloride demonstrates a dose-related bone marrow suppression, correlating with the duration of treatment. Quinazosin dihydrochloride highlights the potential toxicity associated with the thiomorpholine analogs in drug design considerations. |
| CAS | 7262-00-2 |
| Formula | C17H25Cl2N5O2 |
| Molar Mass | 402.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Leukocyte and bone marrow effects of a thiomorpholine quinazosin antihypertensive agent |
Quinazosin dihydrochloride
CAS: 7262-00-2 F: C17H25Cl2N5O2 W: 402.32
Quinazosin dihydrochloride is an antihypertensive agent that exhibits activity related to the suppression of granulopoie
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.